Cercar
01/03/2024
Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
Stockbauer, A, Beyer, L, Huber, M, Kreuzer, A, Palleis, C, Katzdobler, S, Rauchmann, BS, Morbelli, S, Chincarini, A, Bruffaerts, R, Vandenberghe, R, Kramberger, MG, Trost, M, Garibotto, V, Nicastro, N, Lathuilière, A, Lemstra, AW, van Berckel, BNM, Pilotto, A, Padovani, A, Ochoa-Figueroa, MA, Davidsson, A, Camacho, V, Peira, E, Bauckneht, M, Pardini, M, Sambuceti, G, Aarsland, D, Nobili, F, Gross, M, Vöglein, J, Perneczky, R, Pogarell, O, Buerger, K, Franzmeier, N, Danek, A, Levin, J, Höglinger, GU, Bartenstein, P, Cumming, P, Rominger, A, Brendel, M. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; DOI:10.1007/s00259-023-06493-w. PMID:37971501. IF:7.600(Q1/1D).
01/01/2022
Prevalence and longitudinal clinical outcomes of negative, moderate, and advanced 18F-flortaucipir PET visual patterns in aging and Alzheimer’s disease
Moscoso A., Heeman F., Camacho V., van Essen M., Grothe M.J., Lin L., Mainta I., Ribaldi F., Devous M.D., Sr., Pontecorvo M.J., Frisoni G.B., Garibotto V., Schöll M.. Prevalence and longitudinal clinical outcomes of negative, moderate, and advanced 18F-flortaucipir PET visual patterns in aging and Alzheimer’s disease. ALZHEIMERS & DEMENTIA. 2022; 18DOI:10.1002/alz.068009. PMID:. IF:(Q/D).
10/10/2024
The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone
Puig, L, Pérez-Hernández, M. The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone. Dermatologic Therapy. 2024; 2024DOI:10.1155/2024/2351576. PMID:. IF:3.400(Q1/2D).
01/06/2026
Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)
Pesqué, D, de Frutos, FJO, Navarro-Triviño, F, Sanz-Sánchez, T, Zaragoza-Ninet, V, Córdoba-Guijarro, S, Miquel-Miquel, J, Silvestre-Salvador, JF, González-Pérez, R, Ruiz-González, I, Mercader-García, P, Serra-Baldrich, E, Carrascosa-Carrillo, JM, Tous-Romero, F, Rodríguez-Serna, M, Gatica-Ortega, ME, Paredes-Suárez, C, Pastor-Nieto, MA, Chicharro, P, Andreu, M, Sánchez-Gilo, A, Pereyra-Rodríguez, JJ, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Gallardo, F, Pujol, RM, García-Doval, I, Borrego, L, Descalzo, MA, Giménez-Arnau, AM. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC). CONTACT DERMATITIS. 2026; 94(6)DOI:10.1111/cod.70089. PMID:41714111. IF:4.600(Q1/1D).